This Amsterdam, Netherlands-based company asked us to create a brand presence in the U.S. for MammaPrint, an FDA-cleared laboratory test that assesses the risk of breast cancer recurrence. Although the test was then well-utilized in other countries, prior attempts to make U.S. inroads through in-licensing had not been successful. When the company elected to take a different approach, they asked us to help build the brand specifically for the U.S. market, as opposed to European markets. Included in our work were print collateral, trade show booths, and website development. We also arranged for Spanish, Italian and Bulgarian translations of marketing materials. www.agendia.com